Exenatide effects on glucose metabolism and metabolic disorders common to overweight and obese patients with type 2 diabetes (original) (raw)

Drug Development Research, 2006

Abstract

... Author Information. 1 Eli Lilly and Company, Indianapolis, Indiana. 2 Amylin Pharmaceuticals, San Diego, California. Email: James K. Malone (jkmalone@lilly.com). *Correspondence: James K. Malone, Eli Lilly and Company, Indianapolis, IN. Publication History. ...

James Malone hasn't uploaded this paper.

Let James know you want this paper to be uploaded.

Ask for this paper to be uploaded.